<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: While diphenhydramine is a <z:chebi fb="11" ids="18295">histamine</z:chebi> H(1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, the agent has been shown to inhibit <z:chebi fb="11" ids="18295">histamine</z:chebi>-N-methyltransferase, a <z:chebi fb="11" ids="18295">histamine</z:chebi> inactivating enzyme in the brain </plain></SENT>
<SENT sid="1" pm="."><plain>Since an increase in the brain concentration of <z:chebi fb="11" ids="18295">histamine</z:chebi> ameliorates reperfusion injury after <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, effects of postischaemic administration of diphenhydramine were evaluated in rats treated with l-histidine, a precursor of <z:chebi fb="11" ids="18295">histamine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The right middle cerebral artery was occluded for 2h, and the <z:mpath ids='MPATH_124'>infarct</z:mpath> size was determined 24h after reperfusion of cerebral blood flow </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002181'>Brain oedema</z:hpo> was evaluated by comparing the area of the right hemisphere to that of the left hemisphere </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> provoked marked damage in saline-treated control rats, and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes in the striatum and cerebral cortex were 56 (49-63) mm(3) and 110 (72-148) mm(3), respectively (means and 95% confidence intervals, n=6) </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of l-histidine (1000mg/kg, intraperitoneal) immediately after reperfusion did not affect the <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="6" pm="."><plain>Simultaneous administration of diphenhydramine (20mg/kg, intraperitoneal) with l-histidine reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size to 25% and 21% of that in the control group, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The combination therapy completely reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-induced <z:hpo ids='HP_0002181'>brain oedema</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Because <z:chebi fb="11" ids="18295">histamine</z:chebi> H(1) action does not influence ischaemic brain damage, elevation of the central <z:chebi fb="11" ids="18295">histamine</z:chebi> concentration by blockade of <z:chebi fb="11" ids="18295">histamine</z:chebi>-N-methyltransferase may be a likely mechanism responsible for the alleviation </plain></SENT>
</text></document>